No Detail Found!

Frequency of drug induced hyperglycemia during remission induction therapy in adults with acute lymphoblastic leukemia

Author(s)
Abdul Ali Wajid Combined Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi,Pakistan
Riaz Ahmad Combined Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi,Pakistan
Iftikhar Hussain Combined Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi,Pakistan
Imtenan Sharif Combined Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi,Pakistan
Amjad Khan Combined Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi,Pakistan
Assam Ahmed Combined Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi,Pakistan
Abstract
Objectives: To determine the frequency of drug induced hyperglycemia during remission induction and its associated risk factors in adult acute lymphoblastic leukemia (ALL) patients. Study Design: Cross sectional study. Place and Duration of Study: Combined Military Hospital, Rawalpindi Pakistan, from May 2017 to Nov 2017. Material and Methods: Fifty one adult patients of newly diagnosed ALL were enrolled in the study. Inclusion criteria included, eighteen years or older, treatment naïve. Patients with history of diabetes, on-going treatment or were taking drugs causing hyperglycemia were excluded from the study. Possible risk factors were recorded including age, body mass index (BMI), gender, family history of diabetes, history of hypertension and disease risk stratification for ALL. Patients were started on standard or augmented Berlin-Frankfurt-Münster (BFM) protocol according to risk category. Fasting and random glucose levels were done twice a week during induction chemotherapy. Hyperglycemia was diagnosed when patients experienced blood glucose greater than 126 mg/dL as fasting or greater than 200mg/dL as post prandial. Data were analyzed using SPSS version 23. Results: Eighteen of our fifty one enrolled patients (35.3%) experienced hyperglycemia during induction chemotherapy. There was also significant increase in fasting blood sugar levels from baseline readings after induction chemotherapy (p-value<0.001). Univariate analysis demonstrated significant association between fasting high blood sugar after induction chemotherapy with age (p-value <0.001) and BMI (p-value=0.034). While on multivariate analysis only age (p<0.001) was found to have significant association with hyperglycemia. Conclusion: Hyperglycemia was observed in less than half of our adult ALL patients during induction chemotherapy. Age was a significant risk factor associated with hyperglycemia.
Publication Details
Page(s) 1059-1065
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 68, Issue: 5, Year: 2018

Request the full text from PASTIC

Keywords
Body Mass Index, hyperglycemia, Lymphoblastic leukemia.
0

Citations

0

Downloads

139

Views